FlagFlag

Magnolia’s perspective on psychedelics (in Dutch)

In episode 158 of the Dutch podcast De Balanskliniek, Magnolia founder Ingmar de Gooijer talks about psychedelics as a product. He started his career in the pharmaceutical industry and knows how a medicine is brought to market. Does that work the same way for psychedelics, or is it different? He also discusses Magnolia’s philosophy and how its programs with psychedelics are carried out.

Share this on:

Most popular insights